癌症中的蛋白质脂化:机制,失调和新兴药物标
Edward W Tate1,2, Lior Soday3, Ana Losada de la Lastra3
1Department of Chemistry, Imperial College London, London, UK. e.tate@imperial.ac.uk.
Nature reviews. Cancer
|February 29, 2024
概括
蛋白质脂化是一种关键的翻译后修饰 (PTM),影响超过1000种蛋白质,提供了新的癌症治疗点. 研究正在推进,以识别和药物治疗这些途径,用于新的瘤治疗.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 蛋白质脂化是一种关键的翻译后修饰 (PTM),涉及40多种酶和1000多种基质.
- 不调节的脂化影响癌症的发病,进展和免疫力,影响coproteins和信号分子等关键蛋白质.
- 向脂化通路为癌症治疗中调节"不可抗药"coproteins提供了一个独特的策略.
研究的目的:
- 审查最近在癌症中识别向蛋白质脂化途径方面的进展.
- 总结目前的脂质调节疗法药物发现技术的最新进展.
- 概述针对蛋白质脂化向的新型瘤疗法临床试验的现状.
主要方法:
- 最近科学出版物和临床试验数据的文献综述.
- 分析识别脂化点及其作用的技术挑战.
- 脂化PTM与更成熟的PTM如酸化和乙化在癌症药物发现中的比较.
主要成果:
- 超过150种coproteins被脂化,影响癌细胞信号传递,贩运,新陈代谢和免疫力.
- 在目标识别和理解脂化在癌症中的作用方面,技术障碍仍然存在.
- 对脂化通路的药物发现落后于其他PTM,目前正在进行有限的临床试验.
结论:
- 蛋白质脂化通路是癌症治疗的有希望的,但尚未被探索的前沿领域.
- 克服技术挑战对于释放瘤学中向蛋白质脂化治疗的全部治疗潜力至关重要.
- 在确定标和正在进行的临床试验方面取得的进展为调节蛋白质脂化的新型癌症治疗提供了希望.
更多相关视频
09:34Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
9.0K
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Overview of Lipid Metabolism
1.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
